KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Exelixis (EXEL) Return on Sales (2016 - 2026)

Historic Return on Sales for Exelixis (EXEL) over the last 17 years, with Q1 2026 value amounting to 0.41%.

  • Exelixis' Return on Sales rose 1600.0% to 0.41% in Q1 2026 from the same period last year, while for Jan 2026 it was 0.34%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.34% for FY2026, which is 1000.0% up from last year.
  • As of Q1 2026, Exelixis' Return on Sales stood at 0.41%, which was up 1600.0% from 0.32% recorded in Q4 2025.
  • Over the past 5 years, Exelixis' Return on Sales peaked at 0.41% during Q1 2026, and registered a low of 0.07% during Q4 2022.
  • For the 5-year period, Exelixis' Return on Sales averaged around 0.2%, with its median value being 0.19% (2022).
  • As far as peak fluctuations go, Exelixis' Return on Sales plummeted by -3100bps in 2022, and later skyrocketed by 2500bps in 2023.
  • Exelixis' Return on Sales (Quarter) stood at 0.07% in 2022, then skyrocketed by 350bps to 0.18% in 2023, then rose by 23bps to 0.22% in 2024, then skyrocketed by 48bps to 0.32% in 2025, then grew by 26bps to 0.41% in 2026.
  • Its Return on Sales stands at 0.41% for Q1 2026, versus 0.32% for Q4 2025 and 0.33% for Q3 2025.